共 50 条
- [1] A phase II trial of risk-adapted treatment for muscle invasive bladder cancer after neoadjuvant accelerated MVAC.JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)Geynisman, Daniel M.Abbosh, PhilipZibelman, Matthew R.Feldman, RebeccaMcConkey, David JamesHahn, Noah M.Bivalacqua, TrinityTrabulsi, Edouard JohnLallas, Costas D.Hoffman-Censits, Jean H.Viterbo, RosaliaHorwitz, Eric M.Churilla, Thomas M.Alpaugh, R. KatherineGreenberg, Richard E.Smaldone, Marc C.Uzzo, RobertChen, DavidKutikov, AlexanderPlimack, Elizabeth R.
- [2] NEOADJUVANT ACCELERATED MVAC IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER: A MULTI-INSTITUTIONAL PROSPECTIVELY ACCRUED COHORTJOURNAL OF UROLOGY, 2013, 189 (04): : E214 - E214Mehrazin, RezaPlimack, E.Kutikov, A.Tomaszewski, J.Hoffman-Censits, J.Viterbo, R.Greenberg, R.Ginzburg, S.Corcoran, A.Lallas, C.Trabulsi, E.Wong, Y-N.Boorjian, S.Smaldone, M.Uzzo, R.Chen, D.
- [3] Accelerated MVAC as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladderJOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)Blick, C.Hall, P.Pwint, T.Munro, N.Crew, J.Powles, T.Macaulay, V. M.Al-Terkait, F.Protheroe, A.Chester, J. D.
- [4] Neoadjuvant chemotherapy (MVAC) in locally invasive bladder cancerEUROPEAN JOURNAL OF CANCER, 1996, 32A (08) : 1320 - 1324Sagaster, PFlamm, JFlamm, MMayer, ADonner, GOberleitner, SHavelec, LLepsinger, LLudwig, H
- [5] A phase II study of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: Preliminary resultsJOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Kim, W. Y.Grigson, G. I.Wallen, E. M.Pruthi, R. S.
- [6] Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladderCANCER, 2012, 118 (16) : 3920 - 3927Blick, ChristopherHall, PeterPwint, ThinnAl-Terkait, FaisalCrew, JeremyPowles, ThomasMacaulay, ValentineMunro, NicholasDouglas, DavidKilbey, NevianaProtheroe, AndrewChester, John D.
- [7] A phase II study of neoadjuvant erlotinib (Tarceva) in patients with muscle-invasive bladder cancer undergoing radical cystectomy: Preliminary resultsJOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 209 (03) : S129 - S129Smith, AngelaCoward, MatthewKim, WilliamNielsen, MatthewWallen, EricPruthi, Raj S.
- [8] A phase II study of neoadjuvant erlotinib (tarceva) in patients with muscle-invasive bladder cancer undergoing radical cystectomy: Preliminary resultsJOURNAL OF UROLOGY, 2008, 179 (04): : 119 - 119Pearson, MatthewNix, JeffreyKim, WilliamGrigson, GayleWallen, EricPruthi, Raj S.
- [9] A phase II study of neoadjuvant chemotherapy followed by organ preservation in patients with muscle-invasive bladder cancerASIAN JOURNAL OF UROLOGY, 2022, 9 (03) : 318 - 328Dracham, Chinna BabuKumar, NarendraKumar, SantoshElangovan, ArunYadav, Budhi SinghMavuduru, Ravimohan S.Lal, AnupamGupta, Pramod K.Kapoor, Rakesh
- [10] Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and ToxicityJOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (18) : 1895 - 1901Plimack, Elizabeth R.Hoffman-Censits, Jean H.Viterbo, RosaliaTrabulsi, Edouard J.Ross, Eric A.Greenberg, Richard E.Chen, David Y. T.Lallas, Costas D.Wong, Yu-NingLin, JianqingKutikov, AlexanderDotan, EfratBrennan, Timothy A.Palma, NormaDulaimi, EsselMehrazin, RezaBoorjian, Stephen A.Kelly, William KevinUzzo, Robert G.Hudes, Gary R.